Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-12 Sale |
2024-02-13 4:43 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
1,148 | $67.77 | $77,796 | 1,115,983 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:38 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
597 | $67.77 | $40,457 | 64,606 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:38 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
906 | $64.14 | $58,109 | 194,876 (Indirect Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
906 | $64.14 | $58,109 | 93,601 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:34 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
906 | $64.14 | $58,109 | 151,001 (Indirect Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:31 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
835 | $64.14 | $53,555 | 67,507 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:28 pm |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
1,250 | $65.12 | $81,402 | 46,387 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:26 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
2,843 | $64.14 | $182,345 | 2,039,192 (Indirect Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:23 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
1,250 | $65.22 | $81,524 | 57,208 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:21 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
874 | $64.14 | $56,057 | 1,117,131 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
367 | $64.14 | $23,539 | 65,203 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-24 4:06 pm |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
4,286 | $63.69 | $272,975 | 47,637 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-24 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
7,378 | $63.69 | $469,905 | 58,458 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 7:28 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
13,431 | $65 | $872,961 | 2,042,035 (Indirect Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:17 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
4,184 | $65 | $271,943 | 195,782 (Indirect Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
3,413 | $65 | $221,831 | 94,507 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:13 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
3,551 | $65 | $230,801 | 151,907 (Indirect Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:11 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
2,593 | $65 | $168,535 | 68,342 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:07 pm |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
1,738 | $65 | $112,963 | 51,923 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
1,607 | $65 | $104,449 | 65,836 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
3,913 | $65 | $254,329 | 1,118,005 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:01 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,384 | $65 | $89,954 | 65,570 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:00 pm |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
1,061 | $65 | $68,961 | 39,067 (Direct) |
View |
| 2024-01-17 Sale |
2024-01-18 4:55 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
5,207 | $65.58 | $341,475 | 67,443 (Direct) |
View |
| 2024-01-17 Sale |
2024-01-18 4:54 pm |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
3,276 | $65.58 | $214,840 | 53,661 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:47 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
1,632 | $66.81 | $109,032 | 1,131,723 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:45 pm |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
864 | $66.81 | $57,723 | 52,214 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:43 pm |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
1,632 | $66.81 | $109,032 | 81,603 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:41 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
1,631 | $66.81 | $108,965 | 91,620 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:40 pm |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
1,857 | $66.81 | $124,064 | 99,302 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:38 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
4,240 | $66.81 | $283,268 | 234,499 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:37 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
2,235 | $66.81 | $149,317 | 132,453 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
2,235 | $66.81 | $149,317 | 189,991 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 4:32 pm |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
7,851 | $66.81 | $524,514 | 2,160,300 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 12:24 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
438 | $66.81 | $29,262 | 101,017 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:14 pm |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
2,751 | $60.05 | $165,207 | 32,931 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-16 Option Award |
2024-01-17 4:47 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,743 | $0 | 1,131,723 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:47 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
9,805 | $66.3 | 1,131,723 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:45 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
8,312 | $0 | 52,214 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:45 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
12,086 | $66.3 | 52,214 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:43 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
16,963 | $0 | 81,603 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:43 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
24,666 | $66.3 | 81,603 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:41 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
16,963 | $0 | 91,620 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:41 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer |
24,666 | $66.3 | 91,620 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:40 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
19,508 | $0 | 99,302 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:40 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
28,367 | $66.3 | 99,302 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:38 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
23,748 | $0 | 234,499 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:38 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
34,533 | $66.3 | 234,499 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:37 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
23,748 | $0 | 132,453 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:37 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
34,533 | $66.3 | 132,453 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:36 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
23,748 | $0 | 189,991 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:36 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
34,533 | $66.3 | 189,991 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:33 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
25,445 | $0 | 95,376 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:33 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer |
37,000 | $66.3 | 95,376 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:32 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
72,094 | $0 | 2,160,300 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 4:32 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
104,834 | $66.3 | 2,160,300 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 12:24 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
19,508 | $0 | 101,017 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 12:24 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
28,367 | $66.3 | 101,017 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
3,341 | $0 | 22,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:13 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | FONTEYNE PAUL R. Director |
5,748 | $59.86 | 22,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:12 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director |
3,341 | $0 | 17,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:12 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director |
5,748 | $59.86 | 17,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director |
3,341 | $0 | 17,186 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:10 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director |
5,748 | $59.86 | 17,186 (Direct) |
View |